Unlock instant, AI-driven research and patent intelligence for your innovation.
Application of 2',4'-dihydroxy-6'-methoxyl-3',5'-dimethyl chalcone in preparation of medicaments for treating liver diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of dimethylchalcone and methoxy, which is applied in application, food preparation, drug combination, etc., to achieve the effect of reducing AST value, alleviating mouse mania, and reducing ALT value
Inactive Publication Date: 2011-05-25
EAST CHINA UNIV OF SCI & TECH
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] There is no 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone (2',4'-dihydroxy-6'-methoxy-3',5' -dimethylchalcone, DMC) for the relevant reports on protecting the liver
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0016] Example 1 2', 4'-dihydroxy-6'-methoxy-3', 5'-dimethylchalcone's protective effect on CCl4-induced acute liver cell injury
[0019] CCl4 (Shanghai Lingfeng Chemical Reagent Co., Ltd., analytically pure), biphenyl diester (BDP) (Jiangsu Pengyao Pharmaceutical Co., Ltd.), DMSO (Shanghai Chemical Reagent Company, analytically pure), dipotassium hydrogen phosphate and dihydrogen phosphatePotassium is analytically pure;
[0020] DMC, 2′, 4′-dihydroxy-6′-methoxy-3′, 5′-dimethylchalcone, is extracted and isolated from Hydrangea flower in the laboratory, with a purity of >98% (HPLC) .
[0023] Select a newborn mouse of about 10 g, fast for 24 hours, decapitate the blood, separate the liver aseptically, weigh it, place it in PBS solution, wash the liver until gray...
Embodiment 2
[0033] Example 2 2', 4'-dihydroxy-6'-methoxy-3', 5'-dimethylchalcone's protective effect on CCl4-induced acute liver injury in mice
[0034] Reagents and Drugs:
[0035] ALT (alanine aminotransferase) detection kit and AST (aspartate aminotransferase) detection kit were purchased from Nanjing Jiancheng Biotechnology Co., Ltd.;
[0037] DMC, 2′, 4′-dihydroxy-6′-methoxy-3′, 5′-dimethylchalcone, is extracted and isolated from Hydrangea flower in the laboratory, with a purity of >98% (HPLC) .
[0038] Kunming mice, weighing (25±2) g, male and female, were purchased from Shanghai Slack Experimental Animal Co., Ltd.
[0039] Experimental method and results:
[0040] 60 Kunming mice were rando...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a use of 2',4'-dihydroxy-6'-methoxyl-3',5'-dimethyl chalcone in preparation of liver-protecting medicaments, foods or health care products. The invention further relates to a use of the 2',4'-dihydroxy-6'-methoxyl-3',5'-dimethyl chalcone in the preparation of the medicaments, the foods or the health care products for treating or preventing liver diseases and complications thereof. The 2',4'-dihydroxy-6'-methoxyl-3',5'-dimethyl chalcone is found to have an obvious protecting role for in vitro liver cell injuries through the research of the invention, and can be used for preparing the liver-protecting medicaments, the foods or the health care products; and the 2',4'-dihydroxy-6'-methoxyl-3',5'-dimethyl chalcone further has an obvious repair role for in vivo liver organ injuries, and can be used for preparing the medicaments, the foods or the health care products for treating or preventing liver diseases and the complications thereof, thereby bringing the gospel to patients with the liver diseases and being applicable to large-scale popularization and application.
Description
technical field [0001] The present invention relates to the technical field of application of compounds, in particular to the technical field of application of chalcones, specifically a 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethyl Application of chalcone in preparation of medicine for treating liver diseases. Background technique [0002] my country is an area with a high incidence of liver disease, and hepatitis patients account for more than 10% of the total population. At present, anti-hepatitis drugs commonly used in clinic can be roughly divided into three categories: antiviral drugs, immunomodulatory drugs and hepatoprotective drugs. At present, there are 12 million people in the country suffering from chronic liver disease, and 300,000 people are killed by liver disease every year. It is noteworthy that in recent years, the prevalence of fatty liver has been on the rise. After B-ultrasound examination, the prevalence is as high as 30%. [0003] Liver diseases are most...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.